Contact Information
Company Information
Company
Y-mAbs Therapeutics, Inc.
Annual Revenue
87700000.0
Technologies
Cloudflare DNS
Sendgrid
ExactTarget
Outlook
Microsoft Office 365
CloudFlare Hosting
WordPress.org
Google Font API
Mobile Friendly
New Relic
Google Analytics
Google Tag Manager
Bootstrap Framework
Remote
Keywords
biotechnology: pharmaceutical preparations
health care
biotechnology research
biopharmaceuticals
immunotherapy
cancer treatment
pediatric oncology
adult oncology
antibody therapies
danyelza
neuroblastoma
osteosarcoma
medulloblastoma
dipg
dsrct
radioimmunotherapy
companion diagnostics
clinical trials
expanded access programs
anticancer therapeutics
monoclonal antibodies
sada technology
antigen targeting
biologics manufacturing
targeted therapies
pharmaceutical development
patient safety
pharmacovigilance
drug commercialization
healthcare professionals
antibody-based therapies
medical oversight
clinical benefit
unmet medical needs
global partnerships
biotechnology innovations
drug efficacy
patient family support
adverse event reporting
clinical pipelines
research collaborations
novel therapies
regulatory compliance
drug safety
healthcare access
treatment advancements
biopharma industry
medical affairs
oncology drug development
patient-centered care
translational medicine
oncology
pediatric cancer
high-risk neuroblastoma
naxitamab-gqgk
bispecific antibodies
gd2-targeting
b7-h3-targeting
rare diseases
patient support
innovative therapies
advanced antibody technologies
global reach
cancer care
therapeutic products
cancer immunotherapy
antibody engineering
collaboration
research partnerships
fda-approved therapies
patient demographics
specialized treatments
cancer patients
therapeutic innovation
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans